234 related articles for article (PubMed ID: 22864477)
1. Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation.
Nittner D; Lambertz I; Clermont F; Mestdagh P; Köhler C; Nielsen SJ; Jochemsen A; Speleman F; Vandesompele J; Dyer MA; Schramm A; Schulte JH; Marine JC
Nat Cell Biol; 2012 Sep; 14(9):958-65. PubMed ID: 22864477
[TBL] [Abstract][Full Text] [Related]
2. Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo.
Lambertz I; Nittner D; Mestdagh P; Denecker G; Vandesompele J; Dyer MA; Marine JC
Cell Death Differ; 2010 Apr; 17(4):633-41. PubMed ID: 20019750
[TBL] [Abstract][Full Text] [Related]
3. The RB protein family in retinal development and retinoblastoma: new insights from new mouse models.
Bremner R; Chen D; Pacal M; Livne-Bar I; Agochiya M
Dev Neurosci; 2004; 26(5-6):417-34. PubMed ID: 15855771
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between Rb and Arf in suppressing mouse retinoblastoma.
Conkrite K; Sundby M; Mu D; Mukai S; MacPherson D
J Clin Invest; 2012 May; 122(5):1726-33. PubMed ID: 22484813
[TBL] [Abstract][Full Text] [Related]
5. Stop the dicing in hematopoiesis: what have we learned?
Alemdehy MF; Erkeland SJ
Cell Cycle; 2012 Aug; 11(15):2799-807. PubMed ID: 22801545
[TBL] [Abstract][Full Text] [Related]
6. Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.
Busch M; Große-Kreul J; Wirtz JJ; Beier M; Stephan H; Royer-Pokora B; Metz K; Dünker N
Int J Cancer; 2017 Aug; 141(3):549-560. PubMed ID: 28481041
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma.
Kandalam MM; Beta M; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2012; 18():2279-87. PubMed ID: 22969266
[TBL] [Abstract][Full Text] [Related]
8. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
[TBL] [Abstract][Full Text] [Related]
9. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
Yang Y; Mei Q
Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
[TBL] [Abstract][Full Text] [Related]
10. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
[TBL] [Abstract][Full Text] [Related]
11. miR‑34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGE‑A/p53 signaling.
Yang G; Fu Y; Lu X; Wang M; Dong H; Li Q
Int J Oncol; 2019 Jan; 54(1):177-187. PubMed ID: 30387834
[TBL] [Abstract][Full Text] [Related]
12. Unique haploinsufficient role of the microRNA-processing molecule Dicer1 in a murine colitis-associated tumorigenesis model.
Yoshikawa T; Otsuka M; Kishikawa T; Takata A; Ohno M; Shibata C; Kang YJ; Yoshida H; Koike K
PLoS One; 2013; 8(9):e71969. PubMed ID: 24023722
[TBL] [Abstract][Full Text] [Related]
13. Silencing of Dicer1 temporally separates pro- and anti-apoptotic signaling and confers susceptibility to chemotherapy in p53 mutated cells.
Nekova TS; Kneitz S; Einsele H; Stuhler G
Cell Cycle; 2014; 13(14):2192-8. PubMed ID: 24846461
[TBL] [Abstract][Full Text] [Related]
14. miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma.
Conkrite K; Sundby M; Mukai S; Thomson JM; Mu D; Hammond SM; MacPherson D
Genes Dev; 2011 Aug; 25(16):1734-45. PubMed ID: 21816922
[TBL] [Abstract][Full Text] [Related]
15. DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.
Sun X; Tang SC; Xu C; Wang C; Qin S; Du N; Liu J; Zhang Y; Li X; Luo G; Zhou J; Xu F; Ren H
J Cell Mol Med; 2015 Jun; 19(6):1357-65. PubMed ID: 25702703
[TBL] [Abstract][Full Text] [Related]
16. Regulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development.
To KH; Pajovic S; Gallie BL; Thériault BL
BMC Cancer; 2012 Feb; 12():69. PubMed ID: 22336108
[TBL] [Abstract][Full Text] [Related]
17. Dicer cooperates with p53 to suppress DNA damage and skin carcinogenesis in mice.
Lyle S; Hoover K; Colpan C; Zhu Z; Matijasevic Z; Jones SN
PLoS One; 2014; 9(6):e100920. PubMed ID: 24979267
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the p53 pathway in peripheral blood of retinoblastoma patients; potential biomarkers.
Martínez-Sánchez M; Moctezuma-Dávila M; Hernandez-Monge J; Rangel-Charqueño M; Olivares-Illana V
PLoS One; 2020; 15(6):e0234337. PubMed ID: 32502182
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
Liu Y; Liang G; Wang H; Liu Z
Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
[TBL] [Abstract][Full Text] [Related]
20. The molecular biology of retinoblastoma.
Brantley MA; Harbour JW
Ocul Immunol Inflamm; 2001 Mar; 9(1):1-8. PubMed ID: 11262663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
